CD68 and skin basal cell carcinoma: Furthermore, comparisons of the inflammatory infiltrates of BCC tumors pre- and post-imiquimod treatment have shown that the predominant infiltrating inflammatory cells were CD3+ and CD8+ T-cells, although CD68+ cells (macrophages) also increased [16].